COST-EFFECTIVENESS OF ADALIMUMAB IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS (SUB-ACUTE) IN THE UK

Hongbo Yang  1     Alistair Curry  2     Song Wang  3     MIn A. Yang  1     Martha Skup  3     Jingdong Chao  3     Yanjun Bao  3    
1 Analysis Group, Inc., Boston, United States
2 Abbvie Ltd, Berkshire, United Kingdom
3 Abbvie Inc., North Chicago, United States

Conference
UEG Week 2014

Citation
United European Gastroenterology Journal; 2014: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing